Assignee profile:

SLAYBACK PHARMA LLC

City:

Princeton, New Jersey

Country:

United States

Published Applications:

66

Last publication date:

2026-03-12

Patent Grants:

45

Last grant date:

2026-01-13

Top Inventors for applications by SLAYBACK PHARMA LLC

These are the the leading inventors for applications assigned to SLAYBACK PHARMA LLC:

Recent patent applications by SLAYBACK PHARMA LLC

SLAYBACK PHARMA LLC based in Princeton, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-03-12
US20260069570A1
Human necessities

STABLE PHARMACEUTICAL COMPOSITIONS OF EDARAVONE

#2 | 2025-08-28 ✅ Patent 12,521,383 granted on 2026-01-13
US20250268881A1
Human necessities

STABLE PHARMACEUTICAL COMPOSITIONS OF APIXABAN

#3 | 2025-08-28 ✅ Patent 12,491,178 granted on 2025-12-09
US20250268865A1
Human necessities

STABLE PHARMACEUTICAL COMPOSITIONS OF EDARAVONE

#4 | 2025-08-07
US20250248987A1
Human necessities

PHARMACEUTICAL COMPOSITIONS OF CABOZANTINIB

#5 | 2025-07-24
US20250235431A1
Human necessities

STABLE PHARMACEUTICAL COMPOSITIONS OF EDARAVONE

#6 | 2025-07-10
US20250221978A1
Human necessities

STABLE PHARMACEUTICAL COMPOSITIONS OF APIXABAN

#7 | 2025-06-19
US20250195535A1
Human necessities

PHARMACEUTICAL LIQUID COMPOSITIONS OF MELOXICAM

#8 | 2025-05-29
US20250170078A1
Human necessities

STABLE PHARMACEUTICAL COMPOSITIONS OF HYDROXYUREA

#9 | 2025-05-15 ✅ Patent 12,440,474 granted on 2025-10-14
US20250152558A1
Human necessities

STABLE PHARMACEUTICAL COMPOSITIONS OF CLONIDINE

#10 | 2025-03-13
US20250082617A1
Human necessities

STABLE PHARMACEUTICAL COMPOSITIONS OF APIXABAN

#11 | 2025-02-20
US20250057855A1
Human necessities

PHARMACEUTICAL COMPOSITIONS OF MIFEPRISTONE

#12 | 2025-02-13
US20250049824A1
Human necessities

STABLE PHARMACEUTICAL COMPOSITIONS OF CYCLOPHOSPHAMIDE

#13 | 2025-01-30
US20250032586A1
Human necessities

STABLE LIQUID COMPOSITIONS OF GLUCAGON

#14 | 2025-01-30
US20250032508A1
Human necessities

PHARMACEUTICAL COMPOSITIONS OF TESTOSTERONE

#15 | 2025-01-23 ✅ Patent 12,357,627 granted on 2025-07-15
US20250025456A1
Human necessities

PHARMACEUTICAL COMPOSITIONS OF CABOZANTINIB

#16 | 2024-10-24 ✅ Patent 12,419,867 granted on 2025-09-23
US20240350459A1
Human necessities

STABLE PHARMACEUTICAL COMPOSITIONS OF BENDAMUSTINE

#17 | 2024-08-29 ✅ Patent 12,343,330 granted on 2025-07-01
US20240285582A1
Human necessities

STABLE PHARMACEUTICAL COMPOSITIONS OF EDARAVONE

#18 | 2024-06-27
US20240207278A1
Human necessities

PHARMACEUTICAL COMPOSITIONS OF TOFACITINIB FOR ORAL ADMINISTRATION

#19 | 2024-06-20 ✅ Patent 12,213,972 granted on 2025-02-04
US20240197705A1
Human necessities

Stable pharmaceutical compositions of apixaban

#20 | 2024-06-13 ✅ Patent 12,151,020 granted on 2024-11-26
US20240189222A1
Human necessities

Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate

#21 | 2024-06-06
US20240180934A1
Human necessities

STABLE PHARMACEUTICAL COMPOSITIONS OF CYCLOPHOSPHAMIDE

#22 | 2024-05-02 ✅ Patent 12,263,176 granted on 2025-04-01
US20240139204A1
Human necessities

Pharmaceutical liquid compositions of meloxicam

#23 | 2024-04-25
US20240131018A1
Human necessities

PHARMACEUTICAL COMPOSITIONS OF CABOZANTINIB

#24 | 2024-04-18 ✅ Patent 12,133,854 granted on 2024-11-05
US20240122944A1
Human necessities

Pharmaceutical compositions of mifepristone

#25 | 2024-04-04 ✅ Patent 12,133,912 granted on 2024-11-05
US20240108571A1
Human necessities

Stable pharmaceutical compositions of succinylcholine chloride

#26 | 2024-03-07 ✅ Patent 12,208,086 granted on 2025-01-28
US20240075014A1
Human necessities

Stable pharmaceutical compositions of bendamustine

#27 | 2024-02-15
US20240050416A1
Human necessities

Stable Pharmaceutical Compositions of Apixaban

#28 | 2024-01-11 ✅ Patent 12,403,140 granted on 2025-09-02
US20240009188A1
Human necessities

PHARMACEUTICAL COMPOSITIONS OF NILOTINIB

#29 | 2023-12-14 ✅ Patent 11,957,685 granted on 2024-04-16
US20230398120A1
Human necessities

Pharmaceutical compositions of tofacitinib for oral administration

#30 | 2023-11-30 ✅ Patent 12,128,089 granted on 2024-10-29
US20230381282A1
Human necessities

Stable liquid compositions of glucagon

#31 | 2023-10-05 ✅ Patent 11,844,784 granted on 2023-12-19
US20230310384A1
Human necessities

Stable pharmaceutical compositions of bendamustine

#32 | 2023-09-28
US20230301945A1
Human necessities

STABLE PHARMACEUTICAL COMPOSITIONS OF HYDROXYUREA

#33 | 2023-09-14 ✅ Patent 12,194,028 granted on 2025-01-14
US20230285368A1
Human necessities

Stable pharmaceutical compositions of apixaban

#34 | 2023-09-14 ✅ Patent 11,857,524 granted on 2024-01-02
US20230285341A1
Human necessities

Stable oral suspensions of baclofen

#35 | 2023-08-31 ✅ Patent 12,138,255 granted on 2024-11-12
US20230270736A1
Human necessities

Pharmaceutical compositions of cabozantinib

#36 | 2023-08-10 ✅ Patent 12,138,271 granted on 2024-11-12
US20230248742A1
Human necessities

Pharmaceutical compositions of testosterone

#37 | 2023-07-25 ✅ Patent 11,707,450 granted on 2023-07-25
US17877476
Human necessities

Stable pharmaceutical compositions of bendamustine

#38 | 2023-06-15 ✅ Patent 11,679,105 granted on 2023-06-20
US20230181561A1
Human necessities

Pharmaceutical compositions of cabozantinib

#39 | 2023-05-18 ✅ Patent 12,233,049 granted on 2025-02-25
US20230149359A1
Human necessities

Stable pharmaceutical compositions of clonidine

#40 | 2023-05-18 ✅ Patent 11,938,217 granted on 2024-03-26
US20230149294A1
Human necessities

Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate

#41 | 2023-05-04 ✅ Patent 11,696,906 granted on 2023-07-11
US20230139109A1
Human necessities

Stable oral suspensions of baclofen

#42 | 2023-04-20 ✅ Patent 11,931,370 granted on 2024-03-19
US20230119069A1
Human necessities

Stable pharmaceutical compositions of cyclophosphamide

#43 | 2023-03-23 ✅ Patent 11,872,305 granted on 2024-01-16
US20230091021A1
Human necessities

Stable pharmaceutical compositions of succinylcholine chloride

#44 | 2023-03-23
US20230086729A1
Human necessities

STABLE PHARMACEUTICAL COMPOSITIONS OF SUCCINYLCHOLINE CHLORIDE

#45 | 2023-03-16 ✅ Patent 11,878,025 granted on 2024-01-23
US20230085008A1
Human necessities

Pharmaceutical compositions of mifepristone

#46 | 2023-01-26 ✅ Patent 11,564,898 granted on 2023-01-31
US20230028957A1
Human necessities

Stable oral suspensions of baclofen

#47 | 2022-12-08
US20220387418A1
Human necessities

PHARMACEUTICAL COMPOSITIONS OF CABOZANTINIB

#48 | 2022-11-17
US20220362235A1
Human necessities

PHARMACEUTICAL COMPOSITIONS OF CABOZANTINIB

#49 | 2022-11-03 ✅ Patent 11,484,518 granted on 2022-11-01
US20220347140A1
Human necessities

Stable oral suspensions of baclofen

#50 | 2022-09-08
US20220280500A1
Human necessities

PHARMACEUTICAL COMPOSITIONS OF CABOZANTINIB

#51 | 2022-08-25 ✅ Patent 11,590,122 granted on 2023-02-28
US20220265633A1
Human necessities

Pharmaceutical compositions of cabozantinib

#52 | 2022-06-30 ✅ Patent 11,642,355 granted on 2023-05-09
US20220202830A1
Human necessities

Pharmaceutical compositions of testosterone

#53 | 2021-12-02 ✅ Patent 12,383,491 granted on 2025-08-12
US20210369604A1
Human necessities

READY-TO-USE INJECTABLE PHARMACEUTICAL COMPOSITIONS COMPRISING NEOSTIGMINE AND GLYCOPYRROLATE

#54 | 2021-11-04 ✅ Patent 11,766,438 granted on 2023-09-26
US20210338677A1
Human necessities

Pharmaceutical compositions of tofacitinib for oral administration

#55 | 2021-04-29
US20210121480A1
Human necessities

STABLE PHARMACEUTICAL COMPOSITIONS CONTAINING ESTRADIOL AND PROGESTERONE FOR ORAL ADMINISTRATION

#56 | 2021-03-25 ✅ Patent 11,786,512 granted on 2023-10-17
US20210085657A1
Human necessities

Stable pharmaceutical compositions of dihydroergotamine mesylate

#57 | 2021-03-18 ✅ Patent 11,793,809 granted on 2023-10-24
US20210077485A1
Human necessities

Pharmaceutical compositions of nilotinib

#58 | 2020-12-03 ✅ Patent 10,952,981 granted on 2021-03-23
US20200375932A1
Human necessities

Liquid pharmaceutical compositions of baclofen for oral administration

#59 | 2020-08-20 ✅ Patent 10,874,671 granted on 2020-12-29
US20200261449A1
Human necessities

Pharmaceutical compositions of nilotinib

#60 | 2020-07-30 ✅ Patent 10,702,520 granted on 2020-07-07
US20200237753A1
Human necessities

Pharmaceutical compositions of posaconazole

#61 | 2020-07-16 ✅ Patent 11,103,503 granted on 2021-08-31
US20200222395A1
Human necessities

Pharmaceutical compositions of Lurasidone

#62 | 2020-07-16 ✅ Patent 11,103,502 granted on 2021-08-31
US20200222394A1
Human necessities

Pharmaceutical compositions of lurasidone

#63 | 2019-12-12 ✅ Patent 11,110,054 granted on 2021-09-07
US20190374462A1
Human necessities

Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate

#64 | 2019-10-29 ✅ Patent 10,456,354 granted on 2019-10-29
US16176866
Human necessities

Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate

#65 | 2019-10-10 ✅ Patent 11,311,554 granted on 2022-04-26
US20190307772A1
Human necessities

Pharmaceutical compositions of testosterone

#66 | 2019-10-10 ✅ Patent 11,040,008 granted on 2021-06-22
US20190307681A1
Human necessities

Pharmaceutical compositions of meloxicam

Also check out SLAYBACK PHARMA LLC's (Princeton, United States) applicant profile with 59 patent applications submitted.

AssigneeID:

160658 ⎘